Coston McIsaac & Partners lifted its position in shares of Medtronic plc (NYSE:MDT – Free Report) by 2.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 56,170 shares of the medical technology company’s stock after acquiring an additional 1,580 shares during the quarter. Medtronic accounts for approximately 1.4% of Coston McIsaac & Partners’ investment portfolio, making the stock its 29th biggest holding. Coston McIsaac & Partners’ holdings in Medtronic were worth $5,056,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of MDT. Lynx Investment Advisory acquired a new stake in shares of Medtronic during the 2nd quarter worth approximately $28,000. Tributary Capital Management LLC acquired a new stake in Medtronic during the 1st quarter worth $33,000. Riverview Trust Co acquired a new stake in Medtronic during the 1st quarter worth $39,000. Gleason Group Inc. acquired a new stake in Medtronic during the 2nd quarter worth $42,000. Finally, Opal Wealth Advisors LLC acquired a new position in Medtronic in the second quarter valued at $43,000. 82.06% of the stock is owned by hedge funds and other institutional investors.
Medtronic Price Performance
Shares of MDT stock traded up $0.07 during midday trading on Wednesday, reaching $91.19. 1,141,475 shares of the company were exchanged, compared to its average volume of 6,212,877. The company’s 50 day moving average price is $88.83 and its two-hundred day moving average price is $83.67. The company has a market cap of $116.93 billion, a P/E ratio of 33.13, a PEG ratio of 2.53 and a beta of 0.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.61 and a current ratio of 2.13. Medtronic plc has a 12 month low of $68.84 and a 12 month high of $92.25.
Medtronic Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, October 11th. Stockholders of record on Friday, September 27th were paid a dividend of $0.70 per share. The ex-dividend date was Friday, September 27th. This represents a $2.80 annualized dividend and a dividend yield of 3.07%. Medtronic’s dividend payout ratio is currently 101.82%.
Wall Street Analysts Forecast Growth
MDT has been the topic of several analyst reports. Stifel Nicolaus lifted their target price on shares of Medtronic from $85.00 to $87.00 and gave the company a “hold” rating in a report on Wednesday, August 21st. Barclays upped their price target on shares of Medtronic from $104.00 to $105.00 and gave the company an “overweight” rating in a report on Thursday, August 22nd. Royal Bank of Canada raised shares of Medtronic from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $98.00 to $105.00 in a report on Thursday, October 10th. Citigroup upped their price target on shares of Medtronic from $85.00 to $92.00 and gave the company a “neutral” rating in a report on Tuesday, October 1st. Finally, Wells Fargo & Company upped their price target on shares of Medtronic from $105.00 to $106.00 and gave the company an “overweight” rating in a report on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, eight have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $95.36.
Read Our Latest Research Report on MDT
Medtronic Company Profile
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Further Reading
- Five stocks we like better than Medtronic
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- The 3 Best Retail Stocks to Shop for in August
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Canada Bond Market Holiday: How to Invest and Trade
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc (NYSE:MDT – Free Report).
Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.